Source comparison
CJC-1295 no DAC Ipamorelin Stack: Protocol Comparison
Research protocols for the CJC-1295 no DAC Ipamorelin stack vary based on study duration, endpoint measurements, and subject characteristics. The table below compares three standard approaches. Standard Pulsatile 2× daily (morning + evening) 100-150mcg each Up
This comparison does not assign a generated winner or score.
- Research protocols for the CJC-1295 no DAC Ipamorelin stack vary based on study duration, endpoint measurements, and subject characteristics. The table below compares three standard approaches.
- Standard Pulsatile
- 2× daily (morning + evening)
- 100-150mcg each
- Upon waking (fasted) + 2-3h post-dinner
- 8-16 weeks
- Best balance of convenience and efficacy for most research models; maintains physiological pulse patterns without requiring midday administration
- Intensive Pulsatile
- 3× daily (morning + midday + evening)
- 100-200mcg each
- Upon waking + post-training or 1400h + pre-sleep
- 6-12 weeks
- Maximizes pulse frequency and total daily growth hormone secretion; requires strict schedule adherence and increases injection burden
- Conservative Entry
- 1× daily (evening only)
- 50-100mcg each (escalating to 100-150mcg)
- Pre-sleep (fasted, 2-3h post-meal)
- 4-8 weeks initial, then transition to 2× daily
- Appropriate for initial tolerance assessment or dose-response studies; sacrifices significant synergistic benefit compared to multi-dose protocols